LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

DaVita Inc

Fechado

SetorSaúde

137.91 0.22

Visão Geral

Variação de preço das ações

24h

Atual

Mín

137.14

Máximo

137.92

Indicadores-chave

By Trading Economics

Rendimento

-117M

232M

Vendas

-71M

3.2B

P/E

Médio do Setor

13.334

51.198

EPS

2

Margem de lucro

7.204

Funcionários

76,000

EBITDA

-131M

598M

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+15.25% upside

Dividendos

By Dow Jones

Próximos Ganhos

5 de ago. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-2.3B

10B

Abertura anterior

137.69

Fecho anterior

137.91

Sentimento de Notícias

By Acuity

19%

81%

38 / 380 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bullish Evidence

DaVita Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

14 de fev. de 2025, 19:50 UTC

Grandes Movimentos do Mercado

DaVita Stock Declines After Outlook Miss, Berkshire Hathaway Sales

21 de mar. de 2025, 08:19 UTC

Conversa de Mercado

Fresenius Medical Care's Revenue Estimates Lowered by Jefferies on U.S. Volume Concerns -- Market Talk

15 de jul. de 2024, 08:17 UTC

Conversa de Mercado

Fresenius Medical Care, DaVita Brace for Competition, Shift to Home Dialysis -- Market Talk

Comparação entre Pares

Variação de preço

DaVita Inc Previsão

Preço-alvo

By TipRanks

15.25% parte superior

Previsão para 12 meses

Média 158.75 USD  15.25%

Máximo 169 USD

Mínimo 145 USD

Com base em 4 analistas de Wall Street que oferecem metas de preço de 12 meses para DaVita Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

4 ratings

0

Comprar

3

Manter

1

Vender

Pontuação Técnica

By Trading Central

142.36 / 144.275Suporte e Resistência

Curto Prazo

Strong Bullish Evidence

Médio Prazo

Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

38 / 380 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre DaVita Inc

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.